Sponsored Links

Novartis' Gleevec Cancer "Magic Bullet" Extends Life In GIST Patients PDF Print E-mail
Medical News - Colorectal Cancer
Stomach cancer and gastronintestinal stromal tumors (GIST) can be an expensive disease to treat, but for approximately $5,000 a month Novartis AG's cancer pill Gleevec (imatinib) seems to extend the lives of patients with this type of gastrointestinal cancer over the long-term when taking the drug for three years after surgery...

Read more: Colorectal Cancer News From Medical News Today